KKHClass I

Tablet, Resazurin

21 CFR 864.1850 / Hematology

KKH is the FDA product code for Tablet, Resazurin, a class I device type, regulated under 21 CFR 864.1850. As of 2026-09-10, FDA records hold no 510(k) clearances under this code and one recall.

Classification record

Product code: KKH
Device name: Tablet, Resazurin
Regulation: 21 CFR 864.1850
Device class: Class I
Review panel: Hematology
Submission type: 510(k) exempt
Implant: No
Life sustaining or supporting: No
GMP exempt: Yes
Third party review eligible: No
Ingested clearances: 0
Ingested recalls: 1

Companies listing this code with FDA

Companies whose registered establishments list this code

No registered establishment in MDM’s records lists product code KKH.

Recent clearances

Product code KKH

FDA records hold no clearances under product code KKH.

Recent recalls

Product code KKH

Z-1588-2022Class IIFacility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted...Mckesson Medical-Surgical Inc. Corporate Office / initiated 2022-05-25 / 1 Btl

MDM coverage of this record lists here, newest first.

About this record

Sourced from the FDA device classification database, ingested from openFDA. The definition, regulation number, device class and review panel are FDA’s own fields, reproduced without editing.

MDM adds the counts: clearances by decision year, the applicants holding the most clearances under this code, recalls that name it, and the registered establishments that list it. Every count is computed from ingested records only.

Data as of 2026-10-05, the FDA export date for this dataset. Page last changed 2026-09-05. View this product code on fda.gov (opens on fda.gov)